Pyridones in drug discovery: Recent advances

Y Zhang, A Pike - Bioorganic & Medicinal Chemistry Letters, 2021 - Elsevier
Pyridones have been utilized as privileged scaffolds in drug discovery. Some of the
important roles where this class of heterocycles have found utility in medicinal chemistry …

Paving the Rho in cancer metastasis: Rho GTPases and beyond

S Jansen, R Gosens, T Wieland, M Schmidt - Pharmacology & therapeutics, 2018 - Elsevier
Malignant carcinomas are often characterized by metastasis, the movement of carcinoma
cells from a primary site to colonize distant organs. For metastasis to occur, carcinoma cells …

[HTML][HTML] P21-Activated Kinase 1: Emerging biological functions and potential therapeutic targets in Cancer

D Yao, C Li, MSR Rajoka, Z He, J Huang, J Wang… - Theranostics, 2020 - ncbi.nlm.nih.gov
Abstract The p21-Activated kinase 1 (PAK1), a member of serine-threonine kinases family,
was initially identified as an interactor of the Rho GTPases RAC1 and CDC42, which affect a …

The role of p21-activated kinases in cancer and beyond: where are we heading?

H Liu, K Liu, Z Dong - Frontiers in cell and developmental biology, 2021 - frontiersin.org
The p21-activated kinases (PAKs), downstream effectors of Ras-related Rho GTPase Cdc42
and Rac, are serine/threonine kinases. Biologically, PAKs participate in various cellular …

Design, Synthesis, In Vitro and In Vivo Characterization of CDC42 GTPase Interaction Inhibitors for the Treatment of Cancer

N Brindani, LM Vuong, IM Acquistapace… - Journal of Medicinal …, 2023 - ACS Publications
CDC42 GTPases (RHOJ, CDC42, and RHOQ) are overexpressed in multiple tumor types
and activate pathways critical for tumor growth, angiogenesis, and metastasis. Recently, we …

Identification of Novel Cyanopyridones and Pyrido[2,3-d]pyrimidines as Anticancer Agents with Dual VEGFR-2/HER-2 Inhibitory Action: Synthesis, Biological …

T Al-Warhi, AAM Sallam, LR Hemeda, MA El Hassab… - Pharmaceuticals, 2022 - mdpi.com
In the current work, we designed and synthesized three families of non-fused and fused
compounds based on cyanopyridone: derivatives of 6-amino-1, 2-dihydropyridine-3, 5 …

RAC1 as a therapeutic target in malignant melanoma

AC Cannon, C Uribe-Alvarez, J Chernoff - Trends in cancer, 2020 - cell.com
Small GTPases of the RAS and RHO families are related signaling proteins that, when
activated by growth factors or by mutation, drive oncogenic processes. While activating …

Targeting pak1

G Semenova, J Chernoff - Biochemical Society Transactions, 2017 - portlandpress.com
p21-Activated kinase 1 (PAK1) has attracted much attention as a potential therapeutic target
due to its central role in many oncogenic signaling pathways, its frequent dysregulation in …

Accelerating Alchemical Free Energy Prediction Using a Multistate Method: Application to Multiple Kinases

C Champion, R Gall, B Ries, SR Rieder… - Journal of Chemical …, 2023 - ACS Publications
Alchemical free-energy methods based on molecular dynamics (MD) simulations have
become important tools to identify modifications of small organic molecules that improve …

Structure-based design of selective salt-inducible kinase inhibitors

R Tesch, M Rak, M Raab, LM Berger… - Journal of Medicinal …, 2021 - ACS Publications
Salt-inducible kinases (SIKs) are key metabolic regulators. The imbalance in SIK function is
associated with the development of diverse cancers, including breast, gastric, and ovarian …